NEB抗体 新品

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P04374(NEB Antibody) at dilution 1/80. (Original magnification: ×200)    

  
  

**Background of NEB Antibodies**

New England Biolabs (NEB), established in 1974. is a globally recognized leader in the production of reagents for molecular biology, including high-quality antibodies. NEB antibodies are widely utilized in research for their reliability and specificity, supporting applications such as Western blotting, immunofluorescence, chromatin immunoprecipitation (ChIP), and epigenetic studies.

NEB’s antibody development emphasizes rigorous validation to ensure minimal batch-to-batch variability, a common challenge in antibody production. Their portfolio includes antibodies targeting post-translational modifications (e.g., phosphorylation, acetylation, methylation), histone modifications, and key signaling proteins, which are critical for studying cellular processes and disease mechanisms.

A distinguishing feature of NEB antibodies is their integration with recombinant protein technology. Many are produced using recombinant methods, enhancing consistency and reducing reliance on animal-based production. This approach aligns with evolving ethical standards and improves reproducibility in research.

Additionally, NEB provides detailed validation data, including application-specific protocols and peer-reviewed references, ensuring researchers can confidently incorporate these tools into experimental workflows. By combining technical innovation with a commitment to quality, NEB antibodies contribute to advancing molecular and cellular biology research, enabling discoveries in areas such as cancer, epigenetics, and signal transduction.